Brad S. Kahl, MD

Brad S. Kahl, MD


Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Lisa Forbush 

Clinical Interests
  • Lymphoma
  • CLL
Research Interests
  • Clinical trials
  • Novel therapeutics

Dr. Kahl’s clinical interests involve the care of patients with Hodgkin lymphoma, non-Hodgkin’s lymphoma, and chronic lymphocytic leukemia. His research focuses on the development of new treatments for lymphoma patients, with emphasis on novel agents. Particular areas of interest include Mantle Cell Lymphoma and Follicular Lymphoma. He is the principle investigator of numerous clinic trials, including phase I, phase II, and phase III at Washington University. He is also the Chairman of the Eastern Cooperative Oncology Group Lymphoma Committee and oversees all research performed by this organization.



  • 1994-1990: MD, Tufts University School of Medicine, Boston, MA
  • 1989-1984: BS, University of Wisconsin-Madison, Madison, WI

Post-Graduate Training

  • 2000-1998: Hematology Fellow, University of Wisconsin
  • 1998-1997: Chief Medical Resident, University of Wisconsin
  • 1997-1995: Resident, Internal Medicine, University of Wisconsin
  • 1995-1994: Intern, Internal Medicine, University of Wisconsin

Academic Positions

  • present-2015: Professor of Medicine, Washington University School of Medicine
  • 2015-2012: Skoronski Chair of Lymphoma Research
  • 2015-2011: Associate Professor of Medicine (Tenure)
  • 2011-2007: Associate Professor of Medicine (CHS)
  • 2007-2001: Assistant Professor of Medicine, University of Wisconsin
  • 2001-2000: Clinical Instructor in Hematology, University of Wisconsin
  • 2000-1997: Clinical Instructor in Medicine, University of Wisconsin

University & Hospital Appointments

  • present-2016: SCC Protocol Review and Monitoring Committee (Co-Chair)
  • present-2015: Director, Lymphoma Program, Washington University
  • 2015-2001: Director, UW Lymphoma Service

Board Certification

  • 2021, 2011, 2001: ABIM – Hematology
  • 2007, 1997: ABIM – Internal Medicine

Honors & Awards

  • Medical School Alpha Omega Alpha
  • Medical School The Frederick and Bernadette Stohlman Research Award
  • Medical School The Louis Weinstein Clinical Medicine Award
  • Medical School Hewlett-Packard Top Graduate Award
  • 2019: TMAA Dean’s Award at Tufts Medical Reunion
  • 2019-2016: Best Doctors in St. Louis
  • 2019-2005: Best Doctors in America
  • 2018: Teacher of the Year, Washington University Fellowship Program
  • 2018: Levine Cancer Institute Outstanding Achievement Award
  • 2018: Surinder K. Puri Memorial Lecture at Emory University
  • 2014-2004: Madison Magazine “Top Doc” Award
  • 2010: Wilifred T. Weber Award from REX Health Systems
  • 2005: Leukemia and Lymphoma Society Volunteer Leadership Award

National & International Committees

  • present-2009: LRF Scientific Advisory Board
  • present-2009: NCI Lymphoma Steering Committee
  • present-2009: Chair, ECOG Lymphoma Committee
  • present-2008: LRF Mantle Cell Lymphoma Consortium Executive Committee
  • present-2002: ECOG Lymphoma Core Committee
  • 2019-2014: Chair, LRF Mantle Cell Lymphoma Consortium
  • 2018-2013: Chair, LRF Scientific Advisory Board Nominations Committee
  • 2015-2013: ECOG-ACRIN Executive Committee
  • 2011-2008: ASH Committee on Communications
  • 2010-2009: FDA Oncology Drugs Advisory Committee
  • 2007-2006: ASCO Scientific Program Committee: Lymphoma/Myeloma Track
  • 2003-2002: NCI Committee on Common Data Elements for Lymphoma Trials

Editorial Responsibilities

  • present-2018: Contributing Editor, The Hematologist
  • present-2018, 2010-2013: Editorial Board, Journal of Clinical Oncology
  • present-2016: Editorial Board, Blood
  • present-2016: Editor-in-Chief, Clinical Lymphoma, Myeloma and Leukemia
  • 2018: Guest Editor, Best Practice & Research Clinical Hematology: Indolent Lymphoma, Vol 31
  • 2018-2017: Editor-in-Chief, Clinical Advances in Hematology & Oncology
  • 2013-2010: Editorial Board, Leukemia and Lymphoma

Professional Societies

  • present-2000: Eastern Cooperative Oncology Group
  • present-1999: American Association of Cancer Research
  • present-1998: American Society of Clinical Oncology
  • present-1997: American Society of Hematology Associate Member
  • 1998-1995: American College of Physicians Associate Member

Community Service

  • 2010-2005: Leukemia and Lymphoma Society Executive Committee
  • 2010-2004: Leukemia and Lymphoma Society Advisory Board
  • 2015, 2013: Chair, WI Lymphoma Survivorship Conference

NIH Study Sections

  • 2021, 2020, 2016, 2015, 2013: NIH Loan Repayment Program
  • 2019: Special Emphasis Panel for SPOREs
  • 2014: NCI Subcommittee F, Applications for Training and Educational Programs
  • 2010, 2006: Special Emphasis Panel for SPORE in Lymphoma
  • 2009: Special Emphasis Panel/Scientific Review Group ARRA Grants